Combogesic

Product NDC: 0143-9432
Requested package NDC: 0143-9432-27
11-digit product format: 001439432
Labeler code: 0143
Product ID: 0143-9432_186821ca-5ce7-403e-9470-39f6691cd492
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: ACETAMINOPHEN and IBUPROFEN
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Hikma Pharmaceuticals USA Inc
Application: NDA209471
Marketing category: NDA
Marketing start: 2025-01-06
Substance: ACETAMINOPHEN; IBUPROFEN
Active strength: 325; 97.5 mg/1; mg/1
Pharmacologic classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N209471-001	COMBOGESIC	ACETAMINOPHEN; IBUPROFEN	325MG;97.5MG	TABLET / ORAL		RLD, RS	2023-03-01

Orange Book patents#

Current patent rows page 1 of 1 · 2 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N209471-001	11197830	2039-02-27	U-3553	Drug product	2023-03-29
N209471-001	11534407	2039-02-27	U-3553	Drug product	2023-03-29

Orange Book exclusivity#

Current exclusivity rows page 1 of 1 · 1 matching rows.

Application-product, Exclusivity code, Expiration table
Application-product	Exclusivity code	Expiration
N209471-001	NP	2026-03-01

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N209471-001	COMBOGESIC	325MG;97.5MG	TABLET / ORAL	RLD, RS	2023-03-01	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N209471-001	COMBOGESIC	325MG;97.5MG	TABLET / ORAL	RLD, RS	2023-03-01	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N209471-001	COMBOGESIC	325MG;97.5MG	TABLET / ORAL	RLD, RS	2023-03-01	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209471-001	COMBOGESIC	325MG;97.5MG	TABLET / ORAL	RLD, RS	2023-03-01	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N209471-001	COMBOGESIC	325MG;97.5MG	TABLET / ORAL	RLD, RS	2023-03-01	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209471-001	COMBOGESIC	325MG;97.5MG	TABLET / ORAL	RLD, RS	2023-03-01	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209471-001	COMBOGESIC	325MG;97.5MG	TABLET / ORAL	RLD, RS	2023-03-01	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209471-001	COMBOGESIC	325MG;97.5MG	TABLET / ORAL	RLD, RS	2023-03-01	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N209471-001	COMBOGESIC	325MG;97.5MG	TABLET / ORAL	RLD, RS	2023-03-01	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N209471-001	COMBOGESIC	325MG;97.5MG	TABLET / ORAL	RLD	2023-03-01	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N209471-001	COMBOGESIC	325MG;97.5MG	TABLET / ORAL	RLD, RS	2023-03-01	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N209471-001	COMBOGESIC	325MG;97.5MG	TABLET / ORAL	RLD, RS	2023-03-01	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N209471-001	COMBOGESIC	325MG;97.5MG	TABLET / ORAL	RLD	2023-03-01	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N209471-001	COMBOGESIC	325MG;97.5MG	TABLET / ORAL	RLD	2023-03-01	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N209471-001	COMBOGESIC	325MG;97.5MG	TABLET / ORAL	RLD	2023-03-01	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N209471-001	COMBOGESIC	325MG;97.5MG	TABLET / ORAL	RLD	2023-03-01	`8072bd15b7f6…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N209471-001	COMBOGESIC	325MG;97.5MG	TABLET / ORAL	RLD	2023-03-01	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N209471-001	COMBOGESIC	325MG;97.5MG	TABLET / ORAL	RLD	2023-03-01	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N209471-001	COMBOGESIC	325MG;97.5MG	TABLET / ORAL	RLD	2023-03-01	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N209471-001	COMBOGESIC	325MG;97.5MG	TABLET / ORAL	RLD	2023-03-01	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N209471-001	COMBOGESIC	325MG;97.5MG	TABLET / ORAL	RLD	2023-03-01	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N209471-001	COMBOGESIC	325MG;97.5MG	TABLET / ORAL	RLD, RS	2023-03-01	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N209471-001	COMBOGESIC	325MG;97.5MG	TABLET / ORAL	RLD, RS	2023-03-01	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N209471-001	COMBOGESIC	325MG;97.5MG	TABLET / ORAL	RLD, RS	2023-03-01	`053a50430f4f…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N209471-001	COMBOGESIC	325MG;97.5MG	TABLET / ORAL	RLD, RS	2023-03-01	`a50c72e98297…`

Observed Orange Book patent history#

Patent history page 1 of 2 · 71 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-09-14 22:38:34	2026-08	N209471-001	11197830	2039-02-27	U-3553	Drug product	2023-03-29	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209471-001	11534407	2039-02-27	U-3553	Drug product	2023-03-29	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N209471-001	11197830	2039-02-27	U-3553	Drug product	2023-03-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209471-001	11534407	2039-02-27	U-3553	Drug product	2023-03-29	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N209471-001	11197830	2039-02-27	U-3553	Drug product	2023-03-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N209471-001	11534407	2039-02-27	U-3553	Drug product	2023-03-29	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209471-001	10532036	2025-09-22	U-3553		2023-03-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209471-001	11197830	2039-02-27	U-3553	Drug product	2023-03-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209471-001	11534407	2039-02-27	U-3553	Drug product	2023-03-29	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N209471-001	10532036	2025-09-22	U-3553		2023-03-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N209471-001	11197830	2039-02-27	U-3553	Drug product	2023-03-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N209471-001	11534407	2039-02-27	U-3553	Drug product	2023-03-29	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209471-001	10532036	2025-09-22	U-3553		2023-03-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209471-001	11197830	2039-02-27	U-3553	Drug product	2023-03-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209471-001	11534407	2039-02-27	U-3553	Drug product	2023-03-29	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209471-001	10532036	2025-09-22	U-3553		2023-03-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209471-001	11197830	2039-02-27	U-3553	Drug product	2023-03-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209471-001	11534407	2039-02-27	U-3553	Drug product	2023-03-29	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209471-001	10532036	2025-09-22	U-3553		2023-03-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209471-001	11197830	2039-02-27	U-3553	Drug product	2023-03-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209471-001	11534407	2039-02-27	U-3553	Drug product	2023-03-29	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N209471-001	10532036	2025-09-22	U-3553		2023-03-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N209471-001	11197830	2039-02-27	U-3553	Drug product	2023-03-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N209471-001	11534407	2039-02-27	U-3553	Drug product	2023-03-29	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N209471-001	10532036	2025-09-22	U-3553		2023-03-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N209471-001	11197830	2039-02-27	U-3553	Drug product	2023-03-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N209471-001	11534407	2039-02-27	U-3553	Drug product	2023-03-29	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N209471-001	10532036	2025-09-22	U-3553		2023-03-29	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N209471-001	11197830	2039-02-27	U-3553	Drug product	2023-03-29	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N209471-001	11534407	2039-02-27	U-3553	Drug product	2023-03-29	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N209471-001	10532036	2025-09-22	U-3553		2023-03-29	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N209471-001	11197830	2039-02-27	U-3553	Drug product	2023-03-29	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N209471-001	11534407	2039-02-27	U-3553	Drug product	2023-03-29	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N209471-001	10532036	2025-09-22	U-3553		2023-03-29	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N209471-001	11197830	2039-02-27	U-3553	Drug product	2023-03-29	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N209471-001	11534407	2039-02-27	U-3553	Drug product	2023-03-29	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N209471-001	10532036	2025-09-22	U-3553		2023-03-29	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N209471-001	11197830	2039-02-27	U-3553	Drug product	2023-03-29	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N209471-001	11534407	2039-02-27	U-3553	Drug product	2023-03-29	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N209471-001	10532036	2025-09-22	U-3553		2023-03-29	`1e350fbaab3a…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2026-09-14 22:38:34	2026-08	N209471-001	NP	2026-03-01	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N209471-001	NP	2026-03-01	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N209471-001	NP	2026-03-01	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209471-001	NP	2026-03-01	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N209471-001	NP	2026-03-01	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209471-001	NP	2026-03-01	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209471-001	NP	2026-03-01	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209471-001	NP	2026-03-01	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N209471-001	NP	2026-03-01	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N209471-001	NP	2026-03-01	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N209471-001	NP	2026-03-01	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N209471-001	NP	2026-03-01	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N209471-001	NP	2026-03-01	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N209471-001	NP	2026-03-01	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N209471-001	NP	2026-03-01	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N209471-001	NP	2026-03-01	`8072bd15b7f6…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N209471-001	NP	2026-03-01	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N209471-001	NP	2026-03-01	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N209471-001	NP	2026-03-01	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N209471-001	NP	2026-03-01	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N209471-001	NP	2026-03-01	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N209471-001	NP	2026-03-01	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N209471-001	NP	2026-03-01	`3f0d92c62455…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N209471-001	NP	2026-03-01	`a50c72e98297…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Combogesic
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ACETAMINOPHEN	325 mg/1
IBUPROFEN	97.5 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
362O9ITL9D	Internal UNII lookup
WK2XYI10QM	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
2675760	Internal RxNorm lookup
2675765	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
b32651c4-7fa0-415b-91eb-854aa1c28f2a	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
1e73f975-1ce7-705e-2bcf-788b1b5e24ba	Product name	5	20251124
16cde546-8deb-4df2-a072-dab5566ede95	Product name	1	20231003
f6d1b8d7-3bd1-4248-eddd-b60565c88015	Product name	4	20230808
874f4e63-49d2-5150-5d77-052172814ebd	Product name	6	20230105
557673c2-8256-b351-e863-4ec71a5a64b0	Product name	2	20160714
dbc9a339-6215-4e94-9546-57a3b34902ce	Product name	1	20160517
61c18d4e-b552-5478-8fc0-df38b93e3100	Product name	1	20140508
7b2938c9-7eb7-e312-ae90-f54f4240361e	Product name	1	20140508
997601aa-bb5f-6971-6b90-a21132c12c7b	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0143-9432-27	Combogesic	250 in 1 BOTTLE, PLASTIC	TABLET, FILM COATED	250		3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0143-9432	COMBOGESIC (ACETAMINOPHEN AND IBUPROFEN) TABLET, FILM COATED [HIKMA PHARMACEUTICALS USA INC]	3	Current NDC, 1 package rows	20250116_b32651c4-7fa0-415b-91eb-854aa1c28f2a.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Combogesic	ACETAMINOPHEN AND IBUPROFEN	Preferred Pharmaceuticals Inc.	f3cee991-19ef-4a1c-bb14-cbc8b6f32776	2026-08-20	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 209471 application number: NDA209471
Combogesic	ACETAMINOPHEN AND IBUPROFEN	Bryant Ranch Prepack	a4f4ebdd-d4b0-49f4-9a3d-c2acfadc0161	2026-07-27	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 209471 application number: NDA209471
Combogesic	ACETAMINOPHEN AND IBUPROFEN	Preferred Pharmaceuticals Inc.	cd03b658-dba1-4a12-8f6f-ab00da499c05	2025-09-04	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 209471 application number: NDA209471
Combogesic	ACETAMINOPHEN AND IBUPROFEN	Hikma Pharmaceuticals USA Inc	b32651c4-7fa0-415b-91eb-854aa1c28f2a	2025-01-14	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 209471 application number: NDA209471 ndc (package): 0143-9432-27 ndc (product): 0143-9432 ndc11 (package): 00143943227

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
362O9ITL9D	ACETAMINOPHEN	103-90-2	ACETAMINOPHEN
WK2XYI10QM	IBUPROFEN	15687-27-1	IBUPROFEN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
2675760	acetaminophen 325 MG / ibuprofen 97.5 MG Oral Tablet	PSN	b32651c4-7fa0-415b-91eb-854aa1c28f2a	3
2675765	combogesic 325 MG / 97.5 MG Oral Tablet	PSN	b32651c4-7fa0-415b-91eb-854aa1c28f2a	3
2675765	acetaminophen 325 MG / ibuprofen 97.5 MG Oral Tablet [Combogesic]	SBD	b32651c4-7fa0-415b-91eb-854aa1c28f2a	3
2675760	acetaminophen 325 MG / ibuprofen 97.5 MG Oral Tablet	SCD	b32651c4-7fa0-415b-91eb-854aa1c28f2a	3
2675760	acetaminophen 325 MG / ibuprofen 97.5 MG Oral Tablet	SY	b32651c4-7fa0-415b-91eb-854aa1c28f2a	3
2675760	APAP 325 MG / ibuprofen 97.5 MG Oral Tablet	SY	b32651c4-7fa0-415b-91eb-854aa1c28f2a	3
2675765	APAP 325 MG / ibuprofen 97.5 MG Oral Tablet [Combogesic]	SY	b32651c4-7fa0-415b-91eb-854aa1c28f2a	3
2675765	Combogesic 325 MG / 97.5 MG Oral Tablet	SY	b32651c4-7fa0-415b-91eb-854aa1c28f2a	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Sample	Exclude flag	Status
0143-9432-27	00143943227	250 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0143-9432-27)	2025-01-06	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Combogesic	Hikma Pharmaceuticals USA Inc \| AFT Pharmaceuticals US, Inc.	2025-01-14	HUMAN PRESCRIPTION DRUG LABEL	3